Shanghai Haohai Biological Technology Co., Ltd. Announces Resignation of Guo Yongqing as Independent Non-Executive Director, Chairman of Audit Committee, Member of Remuneration and Appraisal Committee and Member of Nomination Committee
December 01, 2023 at 08:51 am
Share
Shanghai Haohai Biological Technology Co., Ltd. announced that according to the requirement that an independent director, in principle, may act as independent director for a maximum of three domestic listed companies under the Measures for the Administration of Independent Directors of Listed Companies promulgated by the China Securities Regulatory Commission on 1 August 2023, in order to fulfill the regulatory requirement as well as considering the personal efforts dedicated to perform his work, Mr. Guo Yongqing has tendered his resignation as an independent non-executive director (INED) of the Fifth Session of the Board and all positions held by him in the special committees under the Board (that is chairman of the Audit Committee, member of the Remuneration and Appraisal Committee and member of the Nomination Committee). The resignation of Mr. Guo Yongqing shall take effect upon the passing of the resolution of election of the new INED at the general meeting.
Shanghai Haohai Biological Technology Co., Ltd. is a China-based company principally engaged in biological technology-related businesses. The businesses of the Company include the manufacture and sales of biological and medical hyaluronate, the research and development of biological engineering and pharmaceutical products and the provision of related services. Its products include orthopedics products, medical aesthetics and wound care products, ophthalmology products and anti-adhesion and hemostasis products, among others. Orthopedics products include sodium hyaluronate injection, medical chitosan and medical sodium hyaluronate gel. Medical aesthetics and wound care products include recombinant human epidermal growth factor (rhEGF), among others. Ophthalmology products include ophthalmic viscoelastic devices and lubricant eye drops. Anti-adhesion and hemostasis products include medical collagen sponges, among others. The Company mainly operates businesses in Mainland China.
Shanghai Haohai Biological Technology Co., Ltd. Announces Resignation of Guo Yongqing as Independent Non-Executive Director, Chairman of Audit Committee, Member of Remuneration and Appraisal Committee and Member of Nomination Committee